C. Falandry, M. Bonnefoy, G. Freyer, and E. Gilson, Biology of cancer and aging: A complex association with cellular senescence, J. Clin. Oncol, vol.32, pp.2604-2610, 2014.
URL : https://hal.archives-ouvertes.fr/hal-01859025

B. K. Kennedy, S. L. Berger, A. Brunet, J. Campisi, A. M. Cuervo et al., Linking aging to chronic disease, Cell, vol.159, pp.709-713, 2014.

A. Grimes and S. B. Chandra, Significance of cellular senescence in aging and cancer, Cancer Res. Treat, vol.41, pp.187-195, 2009.

C. Lopez-otin, M. A. Blasco, L. Partridge, M. Serrano, and G. Kroemer, The hallmarks of aging, vol.153, pp.1194-1217, 2013.

J. R. Aunan, W. C. Cho, and K. Soreide, The Biology of Aging and Cancer: A Brief Overview of Shared and Divergent Molecular Hallmarks. Aging Dis, vol.8, pp.628-642, 2017.

A. I. Rozhok and J. Degregori, The evolution of lifespan and age-dependent cancer risk, Trends Cancer, vol.2, pp.552-560, 2016.

J. W. Shay, Role of Telomeres and Telomerase in Aging and Cancer, Cancer Discov, vol.6, pp.584-593, 2016.

G. Pawelec, Immunosenescence and cancer, Biogerontology, vol.18, pp.717-721, 2017.

E. Barreiro, V. Bustamante, V. Curull, J. Gea, J. L. Lopez-campos et al., Relationships between chronic obstructive pulmonary disease and lung cancer: Biological insights, J. Thorac. Dis, vol.8, pp.1122-1135, 2016.

A. Biswas, H. J. Mehta, and E. E. Folch, Chronic obstructive pulmonary disease and lung cancer: Inter-relationships, Curr. Opin. Pulm. Med, vol.24, pp.152-160, 2018.

M. Murata, Inflammation and cancer, Environ. Health Prev. Med, vol.23, 2018.

M. Serrano, Unraveling the links between cancer and aging, Carcinogenesis, vol.37, 2016.

C. Fitzmaurice, T. F. Akinyemiju, F. H. Lami, T. Alam, R. Alizadeh-navaei et al., Regional, and National Cancer Incidence, Mortality, Years of Life Lost, Years Lived With Disability, and Disability-Adjusted Life-Years for 29 Cancer Groups, 1990 to 2016: A Systematic Analysis for the Global Burden of Disease Study, JAMA Oncol, vol.4, pp.1553-1568, 2018.

A. Micheli, E. Mugno, V. Krogh, M. J. Quinn, M. Coleman et al., Cancer prevalence in European registry areas, Ann. Oncol, vol.13, pp.840-865, 2002.

R. Yancik, Population aging and cancer: A cross-national concern, Cancer J, vol.11, pp.437-441, 2005.

R. Lozano, M. Naghavi, K. Foreman, S. Lim, K. Shibuya et al., Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: A systematic analysis for the Global Burden of Disease Study, Lancet, vol.380, pp.2095-2128, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00827612

S. A. Quaderi and J. R. Hurst, The unmet global burden of COPD, Glob. Health Epidemiol. Genom, vol.3, 2018.

L. Partridge, J. Deelen, and P. E. Slagboom, Facing up to the global challenges of ageing, Nature, vol.561, pp.45-56, 2018.

C. C. Benz and C. Yau, Ageing, oxidative stress and cancer: Paradigms in parallax, Nat. Rev. Cancer, vol.8, pp.875-879, 2008.

B. Bernardes-de-jesus and M. A. Blasco, Telomerase at the intersection of cancer and aging, Trends Genet, vol.29, pp.513-520, 2013.

J. Birch, R. K. Anderson, C. Correia-melo, D. Jurk, G. Hewitt et al., DNA damage response at telomeres contributes to lung aging and chronic obstructive pulmonary disease, Am. J. Physiol. Lung Cell Mol. Physiol, vol.309, pp.1124-1137, 2015.

B. Bottazzi, E. Riboli, and A. Mantovani, Aging, inflammation and cancer, Semin. Immunol, vol.40, pp.74-82, 2018.

A. Caron, D. M. Briscoe, D. Richard, and M. Laplante, DEPTOR at the Nexus of Cancer, Metabolism, and Immunity, Physiol. Rev, vol.98, pp.1765-1803, 2018.

, Cancers, vol.11, p.11, 2019.

R. E. Lawrence and R. Zoncu, The lysosome as a cellular centre for signalling, metabolism and quality control, Nat. Cell Biol, 2019.

Y. Ovadya, T. Landsberger, H. Leins, E. Vadai, H. Gal et al., Impaired immune surveillance accelerates accumulation of senescent cells and aging, Nat. Commun, vol.9, 2018.

L. Raffaghello and V. Longo, Metabolic Alterations at the Crossroad of Aging and Oncogenesis, Int. Rev. Cell Mol. Biol, vol.332, pp.1-42, 2017.

A. Zhavoronkov, P. Mamoshina, Q. Vanhaelen, M. Scheibye-knudsen, A. Moskalev et al., Artificial intelligence for aging and longevity research: Recent advances and perspectives, Ageing Res. Rev, vol.49, pp.49-66, 2019.

C. A. Bellera, M. Rainfray, S. Mathoulin-pelissier, C. Mertens, F. Delva et al., Screening older cancer patients: First evaluation of the G-8 geriatric screening tool, Ann. Oncol, vol.23, pp.2166-2172, 2012.

C. A. Bellera, F. Artaud, M. Rainfray, P. L. Soubeyran, and S. Mathoulin-pelissier, Modeling individual and relative accuracy of screening tools in geriatric oncology, Ann. Oncol, vol.28, pp.1152-1157, 2017.

C. Kenis, D. Bron, Y. Libert, L. Decoster, K. Van-puyvelde et al., Relevance of a systematic geriatric screening and assessment in older patients with cancer: Results of a prospective multicentric study, Ann. Oncol, vol.24, pp.1306-1312, 2013.

C. Kenis, L. Decoster, J. Flamaing, P. R. Debruyne, I. De-groof et al., Adherence to geriatric assessment-based recommendations in older patients with cancer: A multicenter prospective cohort study in Belgium, Ann. Oncol, vol.29, 1987.

A. Magnuson, H. Allore, H. J. Cohen, S. G. Mohile, G. R. Williams et al., Geriatric assessment with management in cancer care: Current evidence and potential mechanisms for future research, J. Geriatr. Oncol, vol.7, pp.242-248, 2016.

S. G. Mohile, W. Dale, M. R. Somerfield, and A. Hurria, Practical Assessment and Management of Vulnerabilities in Older Patients Receiving Chemotherapy: ASCO Guideline for Geriatric Oncology Summary, J. Oncol. Pract, vol.14, pp.442-446, 2018.

J. Guigay, C. Mertens, H. Le-caer, C. Michel, C. Ortholan et al., , vol.104, pp.816-819, 2017.

J. Guigay, H. Le-caer, C. Ortholan, A. Aupérin, C. Michele et al., Treatment of inoperable elderly Head and Neck cancer patients, Curr. Opin. Oncol, 2019.

C. Mertens, H. Le-caer, C. Ortholan, E. Blot, C. Even et al., The ELAN-ONCOVAL (ELderly heAd and Neck cancer-Oncology eValuation) study: Evaluation of the feasibility of a suited geriatric assessment for use by oncologists to classify patients as fit or unfit, Proceedings of the ESMO 2017 Congress, pp.8-12, 2017.

R. Boulahssass, S. Gonfrier, J. M. Ferrero, M. Sanchez, V. Mari et al., Predicting early death in older adults with cancer, Eur. J. Cancer, vol.100, pp.65-74, 2018.

S. Heeke, V. Hofman, E. Long-mira, V. Lespinet, S. Lalvee et al., Use of the Ion PGM and the GeneReader NGS Systems in Daily Routine Practice for Advanced Lung Adenocarcinoma Patients: A Practical Point of View Reporting a Comparative Study and Assessment of 90 Patients, Cancers, vol.10, 2018.

M. Ilie, M. Beaulande, S. Ben-hadj, E. Chamorey, R. Schiappa et al., Chromogenic Multiplex Immunohistochemistry Reveals Modulation of the Immune Microenvironment Associated with Survival in Elderly Patients with Lung Adenocarcinoma, Cancers, vol.9, p.326, 2018.

S. Leroy, J. Benzaquen, A. Mazzetta, S. Marchand-adam, B. Padovani et al., Circulating tumour cells as a potential screening tool for lung cancer (the AIR study): Protocol of a prospective multicentre cohort study in France, BMJ Open, vol.7, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01744875

K. Washetine, S. Heeke, C. Bonnetaud, M. Kara-borni, M. Ilie et al., Establishing a Dedicated Lung Cancer Biobank at the University Center Hospital of Nice (France). Why and How? Cancers, vol.10, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01834086

L. Giovannini-chami, A. Paquet, C. Sanfiorenzo, N. Pons, J. Cazareth et al., The "one airway, one disease" concept in light of Th2 inflammation, Eur. Respir. J, vol.52, 2018.

A. T. Falk, N. Yazbeck, N. Guibert, E. Chamorey, A. Paquet et al., Effect of mutant variants of the KRAS gene on PD-L1 expression and on the immune microenvironment and association with clinical outcome in lung adenocarcinoma patients, Lung Cancer, vol.121, pp.70-75, 2018.

M. Ilie, E. Szafer-glusman, V. Hofman, E. Chamorey, S. Lalvee et al., Detection of PD-L1 in circulating tumor cells and white blood cells from patients with advanced non-small-cell lung cancer, Ann. Oncol, vol.29, pp.193-199, 2018.

S. V. Kemp, D. J. Slebos, A. Kirk, M. Kornaszewska, K. Carron et al., A Multicenter Randomized Controlled Trial of Zephyr Endobronchial Valve Treatment in Heterogeneous Emphysema (TRANSFORM), Am. J. Respir. Crit. Care Med, vol.196, pp.1535-1543, 2017.
URL : https://hal.archives-ouvertes.fr/hal-01963139

D. R. Revinski, L. E. Zaragosi, C. Boutin, S. Ruiz-garcia, M. Deprez et al., CDC20B is required for deuterosome-mediated centriole production in multiciliated cells, Nat. Commun, vol.9, 2018.
URL : https://hal.archives-ouvertes.fr/hal-02064869

J. Benzaquen, J. Boutros, C. Marquette, H. Delingette, and P. Hofman, Lung Cancer Screening, Towards a Multidimensional Approach: Why and How? Cancers, vol.11, 2019.

R. Boulahssass, S. Gonfrier, N. Champigny, S. Lassalle, E. Francois et al., The Desire to Better Understand Older Adults with Solid Tumors to Improve Management: Assessment and Guided Interventions-The French PACA EST Cohort Experience, Cancers, vol.11, 0192.

K. J. Harrington, R. L. Ferris, G. Blumenschein, . Jr, A. D. Colevas et al., Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): Health-related quality-of-life results from a randomised, vol.18, pp.1104-1115, 2017.

A. Bozec, J. Zangari, M. Butori-pepino, M. Ilie, S. Lalvee et al., Vouret-Craviari, V. MiR-223-3p inhibits angiogenesis and promotes resistance to cetuximab in head and neck squamous cell carcinoma, Oncotarget, vol.8, pp.57174-57186, 2017.

M. Ilie, N. Arrighi, and P. Hofman, Fueling the sustainability of Next Generation Biobanks by training. A New Master "Biobanks and Complex Data Management" at the Nice Côte d'Azur University, Proceedings of the Global Biobank Week, pp.13-15, 2017.

F. Casaluce, A. Sgambato, P. Maione, A. Spagnuolo, and C. Gridelli, Lung cancer, elderly and immune checkpoint inhibitors, J. Thorac. Dis, vol.10, pp.1474-1481, 2018.

A. Daste, C. Domblides, M. Gross-goupil, C. Chakiba, A. Quivy et al., Immune checkpoint inhibitors and elderly people: A review, Eur. J. Cancer, vol.82, pp.155-166, 2017.

R. Elias, K. Hartshorn, O. Rahma, N. Lin, and J. E. Snyder-cappione, Aging, immune senescence, and immunotherapy: A comprehensive review, Semin. Oncol, vol.45, pp.187-200, 2018.

C. Helissey, C. Vicier, and S. Champiat, The development of immunotherapy in older adults: New treatments, new toxicities?, J. Geriatr. Oncol, vol.7, pp.325-333, 2016.

R. Kanesvaran, R. Cordoba, and R. Maggiore, Immunotherapy in Older Adults With Advanced Cancers: Implications for Clinical Decision-Making and Future Research, Am. Soc. Clin. Oncol. Educ. Book, pp.400-414, 2018.

C. Falandry, E. Gilson, and K. L. Rudolph, Are aging biomarkers clinically relevant in oncogeriatrics?, Crit. Rev. Oncol. Hematol, vol.85, pp.257-265, 2013.

R. Ferrara, L. Mezquita, E. Auclin, N. Chaput, and B. Besse, Immunosenescence and immunecheckpoint inhibitors in non-small cell lung cancer patients: Does age really matter? Cancer Treat, vol.60, pp.60-68, 2017.